Debrisoquine oxidation phenotype and susceptibility to lung cancer

Br J Clin Pharmacol. 1990 Oct;30(4):653-6. doi: 10.1111/j.1365-2125.1990.tb03832.x.
No abstract available

Publication types

  • Comment
  • Letter

MeSH terms

  • Debrisoquin / metabolism*
  • Debrisoquin / urine
  • Disease Susceptibility
  • Gas Chromatography-Mass Spectrometry
  • Humans
  • Lung Neoplasms / genetics*
  • Lung Neoplasms / metabolism
  • Oxidation-Reduction
  • Phenotype*

Substances

  • Debrisoquin